AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,498,711 | -0.7% | 110,443 | +25.5% | 0.00% | – |
Q2 2023 | $1,509,149 | -3.4% | 87,997 | +13.6% | 0.00% | – |
Q1 2023 | $1,561,945 | -31.8% | 77,439 | -1.0% | 0.00% | – |
Q4 2022 | $2,291,231 | +84.6% | 78,199 | +4.5% | 0.00% | – |
Q3 2022 | $1,241,000 | +4.3% | 74,828 | -1.7% | 0.00% | – |
Q2 2022 | $1,190,000 | -37.9% | 76,140 | -27.1% | 0.00% | – |
Q1 2022 | $1,915,000 | +86.5% | 104,450 | +19.8% | 0.00% | – |
Q4 2021 | $1,027,000 | -44.5% | 87,169 | -1.2% | 0.00% | – |
Q3 2021 | $1,851,000 | – | 88,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |